(Q35821086)

10 August 2017

1 reference

title

The link between LUTS and ED: clinical and basic science evidence (English)

1 reference

10 August 2017

1 reference

2

John P Mulhall

1 reference

10 August 2017

Jonathan D Schiff

1

1 reference

10 August 2017

publication date

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

25

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

470-478

1 reference

Sexual function in 131 patients with benign prostatic hyperplasia before prostatectomy

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Natural history of benign prostatic hypertrophy and acute urinary retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Prostate and sexuality: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

RhoA/Rho-kinase, vascular changes, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Clinical experience in Europe with uroselective alpha1-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Mechanisms of endothelial dysfunction in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Sexual dysfunction in men with lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

High prevalence of benign prostatic hypertrophy in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Association of health-related quality of life and benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Sexual dysfunction in the United States: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

History of 7,093 patients with lower urinary tract symptoms related to benign prostatic hyperplasia treated with alfuzosin in general practice up to 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Endothelial dysfunction and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

A heterogeneous population of alpha 1 adrenergic receptors mediates contraction of human corpus cavernosum smooth muscle to norepinephrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

The relationship between sexual life and urinary condition in the French community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1939-4640.2004.TB02818.X

10.1002/J.1939-4640.2004.TB02818.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference